Measurement of disease activity in ulcerative colitis: Interobserver agreement and predictors of severity

Authors

  • Kelvin T. Thia MD,

    1. Miles & Shirley Fiterman Center for Digestive Diseases, Mayo Clinic, Rochester, Minnesota, USA
    2. Department of Gastroenterology and Hepatology, Singapore General Hospital, Singapore
    3. Presented in part at the Digestive Disease Week 2009 (K.T., E.L., D.P., S.K., W.F., W.T., K.S., S.H., A.Z., W.S.). Interobserver Agreement and Predictors of Assessment of Overall Endoscopic Severity in Ulcerative Colitis. Gastroenterology 2009;136(suppl 1):W1158.
    Search for more papers by this author
  • Edward V. Loftus Jr MD,

    1. Miles & Shirley Fiterman Center for Digestive Diseases, Mayo Clinic, Rochester, Minnesota, USA
    2. Presented in part at the Digestive Disease Week 2009 (K.T., E.L., D.P., S.K., W.F., W.T., K.S., S.H., A.Z., W.S.). Interobserver Agreement and Predictors of Assessment of Overall Endoscopic Severity in Ulcerative Colitis. Gastroenterology 2009;136(suppl 1):W1158.
    Search for more papers by this author
  • Darrell S. Pardi MD,

    1. Miles & Shirley Fiterman Center for Digestive Diseases, Mayo Clinic, Rochester, Minnesota, USA
    2. Presented in part at the Digestive Disease Week 2009 (K.T., E.L., D.P., S.K., W.F., W.T., K.S., S.H., A.Z., W.S.). Interobserver Agreement and Predictors of Assessment of Overall Endoscopic Severity in Ulcerative Colitis. Gastroenterology 2009;136(suppl 1):W1158.
    Search for more papers by this author
  • Sunanda V. Kane MD,

    1. Miles & Shirley Fiterman Center for Digestive Diseases, Mayo Clinic, Rochester, Minnesota, USA
    2. Presented in part at the Digestive Disease Week 2009 (K.T., E.L., D.P., S.K., W.F., W.T., K.S., S.H., A.Z., W.S.). Interobserver Agreement and Predictors of Assessment of Overall Endoscopic Severity in Ulcerative Colitis. Gastroenterology 2009;136(suppl 1):W1158.
    Search for more papers by this author
  • William A. Faubion MD,

    1. Miles & Shirley Fiterman Center for Digestive Diseases, Mayo Clinic, Rochester, Minnesota, USA
    2. Presented in part at the Digestive Disease Week 2009 (K.T., E.L., D.P., S.K., W.F., W.T., K.S., S.H., A.Z., W.S.). Interobserver Agreement and Predictors of Assessment of Overall Endoscopic Severity in Ulcerative Colitis. Gastroenterology 2009;136(suppl 1):W1158.
    Search for more papers by this author
  • William J. Tremaine MD,

    1. Miles & Shirley Fiterman Center for Digestive Diseases, Mayo Clinic, Rochester, Minnesota, USA
    2. Presented in part at the Digestive Disease Week 2009 (K.T., E.L., D.P., S.K., W.F., W.T., K.S., S.H., A.Z., W.S.). Interobserver Agreement and Predictors of Assessment of Overall Endoscopic Severity in Ulcerative Colitis. Gastroenterology 2009;136(suppl 1):W1158.
    Search for more papers by this author
  • Kenneth W. Schroeder MD,

    1. Miles & Shirley Fiterman Center for Digestive Diseases, Mayo Clinic, Rochester, Minnesota, USA
    2. Presented in part at the Digestive Disease Week 2009 (K.T., E.L., D.P., S.K., W.F., W.T., K.S., S.H., A.Z., W.S.). Interobserver Agreement and Predictors of Assessment of Overall Endoscopic Severity in Ulcerative Colitis. Gastroenterology 2009;136(suppl 1):W1158.
    Search for more papers by this author
  • Scott W. Harmsen MS,

    1. Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, Minnesota, USA
    2. Presented in part at the Digestive Disease Week 2009 (K.T., E.L., D.P., S.K., W.F., W.T., K.S., S.H., A.Z., W.S.). Interobserver Agreement and Predictors of Assessment of Overall Endoscopic Severity in Ulcerative Colitis. Gastroenterology 2009;136(suppl 1):W1158.
    Search for more papers by this author
  • Alan R. Zinsmeister PhD,

    1. Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, Minnesota, USA
    2. Presented in part at the Digestive Disease Week 2009 (K.T., E.L., D.P., S.K., W.F., W.T., K.S., S.H., A.Z., W.S.). Interobserver Agreement and Predictors of Assessment of Overall Endoscopic Severity in Ulcerative Colitis. Gastroenterology 2009;136(suppl 1):W1158.
    Search for more papers by this author
  • William J. Sandborn MD

    Corresponding author
    1. Miles & Shirley Fiterman Center for Digestive Diseases, Mayo Clinic, Rochester, Minnesota, USA
    2. Presented in part at the Digestive Disease Week 2009 (K.T., E.L., D.P., S.K., W.F., W.T., K.S., S.H., A.Z., W.S.). Interobserver Agreement and Predictors of Assessment of Overall Endoscopic Severity in Ulcerative Colitis. Gastroenterology 2009;136(suppl 1):W1158.
    • Division of Gastroenterology & Hepatology, 200 First St., S.W. Rochester, MN 55905
    Search for more papers by this author

Abstract

Background:

Endoscopic evaluation plays a pivotal role in the assessment of treatment response in ulcerative colitis (UC). This study aimed to determine the interobserver agreement (IOA) for assessment of mucosal lesions, and to determine lesions predictive of global assessment of endoscopic severity (GAES).

Methods:

Fifty-one UC patients had digital videorecording of their colonoscopic examinations, edited into videoclips representative of five colonic segments (rectum, sigmoid, descending, transverse, ascending/cecum). Seven gastroenterologists specializing in inflammatory bowel disease (IBD) independently and blindly rated individual lesions and endoscopic severity for each segment and globally. Edema, erythema, stricture, loss of haustral folds, rigidity, and pseudopolyps were scored as absent or present while vascular pattern, granularity, ulceration, and bleeding-friability were scored using a predefined severity scale. The GAES was based on a 4-point scale and a 10-cm visual analog scale (VAS). The IOA among raters was estimated using Lin's concordance correlation coefficient (CCC). Strength of agreement was categorized as excellent (0.81–1.00), good (0.61–0.80), moderate (0.41–0.60), and fair (0.21–0.40). Linear regression analysis was used to identify lesions predictive of overall endoscopic severity and develop a scoring system for clinical use.

Results:

Granularity, vascular pattern, ulceration, bleeding/friability, and pseudopolyps had good IOA in most segments. There was excellent agreement for VAS and good agreement for GAES and the VAS was significantly associated with GAES (P < 0.001). Granularity, vascular pattern, ulceration, and bleeding-friability were significant predictors of overall endoscopic severity.

Conclusions:

Granularity, vascular pattern, ulceration, and bleeding-friability demonstrated good reproducibility and were predictors of the GAES in UC patients. (Inflamm Bowel Dis 2011)

Ancillary